KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guardant Health (GH) EBIT Margin: 2017-2025

Historic EBIT Margin for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -37.33%.

  • Guardant Health's EBIT Margin rose 2395.00% to -37.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -49.02%, marking a year-over-year increase of 2540.00%. This contributed to the annual value of -60.02% for FY2024, which is 4011.00% up from last year.
  • Latest data reveals that Guardant Health reported EBIT Margin of -37.33% as of Q3 2025, which was up 18.59% from -45.85% recorded in Q2 2025.
  • In the past 5 years, Guardant Health's EBIT Margin registered a high of -37.33% during Q3 2025, and its lowest value of -137.12% during Q1 2021.
  • Its 3-year average for EBIT Margin is -70.50%, with a median of -61.28% in 2024.
  • In the last 5 years, Guardant Health's EBIT Margin tumbled by 8,540bps in 2021 and then soared by 6,497bps in 2024.
  • Guardant Health's EBIT Margin (Quarterly) stood at -90.84% in 2021, then slumped by 2,431bps to -115.15% in 2022, then slumped by 1,223bps to -127.38% in 2023, then soared by 6,497bps to -62.42% in 2024, then spiked by 2,395bps to -37.33% in 2025.
  • Its EBIT Margin stands at -37.33% for Q3 2025, versus -45.85% for Q2 2025 and -54.57% for Q1 2025.